← Open Payments lookup

KINJAL NAKRANI: Open Payments

NPI 1497367981 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$861 in 28 payments from 16 companies in 2025. Trend: 2023 $57 · 2024 $73 · 2025 $861

Food & beverage: $861
CompanyPaymentsAmount
GlaxoSmithKline, LLC.1$120
GENZYME CORPORATION1$115
United Therapeutics Corporation3$90
Actelion Pharmaceuticals US, Inc.3$84
Boehringer Ingelheim Pharmaceuticals, Inc.3$66
Takeda Pharmaceuticals U.S.A., Inc.2$61
AstraZeneca Pharmaceuticals LP3$56
Merck Sharp & Dohme LLC2$53
ABBVIE INC.2$44
Bayer Healthcare Pharmaceuticals Inc.2$43

Products named: NUCALA, DUPIXENT, Tyvaso, UPTRAVI, GLASSIA, WINREVAIR, CREON, Nubeqa.

Industry payments across FL — which companies pay providers there.